EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Proceedings of the National Academy of Sciences

Topics

Biology

Cancer Oncology

Medicine

Internal Medicine

Pulmonary And Respiratory Medicine

Show all topics

DOI

10.1073/pnas.0405220101

Other Formats

PDF